Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0000905148-25-004140

Chief Accounting Officer sold 1,804 shares at an average $13.19 ($23,788)

From the SEC's structured data for this filing

Trades in this filing

Grant-Huerta Yanina · Chief Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-17 Sale : show line 1 in the form −1,645 $13.19 $21,691 33,613 D
2025-11-17 Sale : show line 2 in the form −85 $13.19 $1,121 33,528 D
2025-11-17 Sale : show line 3 in the form −74 $13.19 $976 33,454 D
Open-market sales · 1,804 sh · avg $13.19 · $23,788
Loading xslF345X05/form4.xml…